Loading quotes...
Forecast
The analysts' average price target is €27.67 (+17.00%). The median is €27.52 (+16.36%).
| Buy |
Â
7 |
| Hold |
Â
13 |
| Sell |
Â
0 |
News Go to news feed
Hims & Hers expands into Australia by renaming Pilot
Hims & Hers is introducing its brand in Australia by renaming the acquired men’s health platform Pilot to Hims. Existing Pilot patients will retain their treatment plans and providers; the offering includes sexual health, weight-loss and hair-loss treatments. The company has expanded customer support to 24/7, introduced new treatment combinations and clinical pathways, and is reorganizing leadership for the market. Hims & Hers acquired Eucalyptus in early 2026; the announcement notes integration, competitive and retention risks. » More on de.investing.com
Hims & Hers placed in Visa monitoring program after spike in weight-loss subscription disputes
Visa enrolled Hims & Hers in its Acquirer Monitoring Program after dispute rates for the company’s weight-loss subscriptions exceeded Visa’s 1.5% threshold. Hims faces an ~$75,000 surcharge in September and must keep disputes below 1.5% for three consecutive months to exit the program. The action compounds regulatory pressure from a recent FTC lawsuit over billing and cancellation practices, though Hims says disputed charges are a small number and is taking corrective steps. Shares tumbled after the news despite strong subscriber growth and rising revenue alongside widening losses and margin pressure. » More on finance.yahoo.com
Hims & Hers in Visa monitoring program after rise in credit card complaints
Hims & Hers was placed in Visa's Acquirer Monitoring Program after the number of credit card complaints in its subscription business for weight-loss products exceeded allowable thresholds in July. Each complaint carries an $8 penalty fee, which, according to internal documents, could result in a bill of nearly $75,000 due in September. Visa is demanding that the complaint rate be reduced to under 1.5% of transactions for three consecutive months; Hims & Hers says the number of disputed charges is relatively small and that it has implemented measures to improve the checkout process. » More on de.investing.com
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 659.97M | 42.77% |
| Gross profit | 421.28M | 19.31% |
| Net profit | -75.61M | 309.66% |
| EBITDA | -55.34M | 250.57% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €5.28B |
Number of shares | 223.08M |
52-week high/low | €56.16 - €11.82 |
| Dividends | No |
Beta | 2.41 |
P/E ratio | -45.10 |
PEG ratio | 1.07 |
P/B ratio | 19.67 |
P/S ratio | 2.38 |
Company profile
Hims & Hers Health, Inc. betreibt eine multidisziplinäre Telemedizin-Plattform, die Verbraucher mit zugelassenen medizinischen Fachkräften verbindet. Das Unternehmen bietet eine Reihe von Gesundheits- und Wellness-Produkten und -Dienstleistungen an, die auf seinen Websites und über seine mobile Anwendung direkt von den Kunden erworben werden können. Darüber hinaus bietet es verschreibungspflichtige Medikamente auf wiederkehrender Basis und laufende Betreuung durch Gesundheitsdienstleister sowie rezeptfreie Arzneimittel und Geräte, Kosmetika und Nahrungsergänzungsmittel an, wobei der Schwerpunkt auf den Bereichen Wellness, sexuelle Gesundheit und Wellness, Hautpflege und Haarpflege liegt. Zu den kuratierten, nicht verschreibungspflichtigen Produkten des Unternehmens gehören Vitamin C, Melatonin, Biotin und Kollagen-Protein-Nahrungsergänzungen in der Wellness-Kategorie; Feuchtigkeitscreme, Seren und Gesichtswäsche in der Hautpflege-Kategorie; Kondome, Climax Delay-Spray und -Tücher, Vibratoren und Gleitmittel in der Kategorie sexuelle Gesundheit und Wellness; und Shampoos, Conditioner, Kopfhaut-Peelings und topische Behandlungen, wie Minoxidil in der Haarpflege-Kategorie. Darüber hinaus bietet das Unternehmen medizinische Beratungsdienste sowie Gesundheits- und Wellnessprodukte über Großhandelspartner an. Der Hauptsitz des Unternehmens befindet sich in San Francisco, Kalifornien.
| Name | Hims & Hers Health |
| CEO | Andrew Dudum |
| Headquarters | San Francisco,
ca USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| IPO | 09/13/2019 |
| Employees | 2,442 |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | HIMS |
Frankfurt | 82W.F |
DĂĽsseldorf | 82W.DU |
MĂĽnchen | 82W.MU |